Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy

JAMA Cardiology - United States
doi 10.1001/jamacardio.2016.3894
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Systemic Light Chain Amyloidosis With Cardiac and Renal Involvements in a Patient With Heart Failure

Cardiology and Cardiovascular Medicine
2017English

EGCG Inhibits Fibrillation of Light Chain 6aJL2-R24g, Associated With Light Chain Amyloidosis

Biophysical Journal
Biophysics
2018English

Apical Myectomy for Patients With Hypertrophic Cardiomyopathy and Advanced Heart Failure

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2020English

Congestive Heart Failure With Preserved Ejection Fraction in a Patient With Light Chain (AL) Amyloidosis and Multiple Myeloma

American Journal of Case Reports
Medicine
2017English

Congenital Anomalies in the Heart With Hypertrophic Cardiomyopathy.

Heart
Cardiovascular MedicineCardiology
1968English

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report

Cardiology Research
Cardiovascular MedicineCardiology
2016English

Treatment Patterns and Outcome Following Initial Relapse or Refractory Disease in Patients With Systemic Light Chain Amyloidosis

American Journal of Hematology
Hematology
2017English

Elevated Cardiac Enzymes in Hypertrophic Cardiomyopathy Patients With Heart Failure – A 20-Year Prospective Follow-Up Study –

Circulation Journal
MedicineCardiovascular MedicineCardiology
2016English

Outcomes of 44 Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion 17p

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy